The prevalence of hypertension was 38%. There were 17 hypertensives and 27 normotensives. The incidence of renal impairment was greater in the hypertensives, 47% vs 18.5% (p=0.04). Mean serum creatinine was also higher higher in this group (p=0.02). The presence of hypertensive renal vascular lesions identified a high-risk subgroup who had a higher incidence of renal functional impairment and worse renal function than the hypertensive group as a whole. Even at an early stage, hypertension and hypertensive renal vascular lesions correlated well with renal functional impairment. Aggressive treatment of hypertension is therefore essential in early lupus nephritis in order to prevent further deterioration of renal function as the disease evolves.
Summary
The prognostic importance of hypertension at the onset of clinical lupus nephritis is not well established. We studied retrospectively 44 patients with lupus nephritis in order to ascertain the prevalence of hypertension at presentation and to investigate a possible association between hypertension and renal functional impairment. A correlation was also sought between hypertension and histological class of lupus nephritis. Hypertension was graded as mild (diastolic 95 -99 mmHg), moderate (100-114) or severe (>115). Impaired renal function (creatinine >120 umoMl) was graded as mild (120-200 pmolll), moderate (200-350 jimol/l), or severe (>350 jymol/l). Histological class and the presence of hypertensive renal vascular lesions was recorded.
The prevalence of hypertension was 38%. There were 17 hypertensives and 27 normotensives. The incidence of renal impairment was greater in the hypertensives, 47% vs 18.5% (p=0.04). Mean serum creatinine was also higher higher in this group (p=0.02). The presence of hypertensive renal vascular lesions identified a high-risk subgroup who had a higher incidence of renal functional impairment and worse renal function than the hypertensive group as a whole. Even at an early stage, hypertension and hypertensive renal vascular lesions correlated well with renal functional impairment. Aggressive treatment of hypertension is therefore essential in early lupus nephritis in order to prevent further deterioration of renal function as the disease evolves.
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The development of arterial hypertension in patients with systemic lupus erythematosus is generally believed to be secondary to underlying lupus glomerulonephritis. 1,2 Indeed, Rosenbaum et aP found that the incidence of hypertension in patients with lupus nephritis increased with both histological activity and loss of renal function. However, Ward and Studenski,4 who followed up 160 patients with lupus nephritis for a median of 6.4 years found that hypertension was an important independent risk factor for the development of end stage renal disease and was not merely a surrogate measure of underlying glomerulonephritis. Furthermore there has been a report of a dissociation of hypertension and lupus nephritis in patients with systemic lupus erythematosus,5 and it is well known that hypertension may be absent even in patients with aggressive lupus histology and significant renal functional impairment.5 This retrospective study was therefore undertaken in order to ascertain the prevalence of hypertension at the onset of clinical lupus nephritis. We also investigated a possible association between hypertension and renal vascular lesions thereof with renal functional impairment. Finally, we searched for a correlation between hypertension and histological class of lupus nephritis.
It was decided to explore these associations on presentation of the disease, as the prognostic importance of hypertension at the onset of nephritis has not been well established. 4 Furthermore, while the detrimental effect of hypertension on renal function late in the course of lupus nephritis has been recognised,6-9 it is nevertheless difficult to draw firm conclusions about its prognostic importance at this stage of the disease, as it may be both a cause and consequence of renal insufficiency.4 Patients The prevalence of hypertension at the onset of clinical lupus nephritis in our patients was 38%, and was not influenced by age or race. This is identical to the prevalence reported by Ward and Studenski,' and is considerably higher than the prevalence of hypertension in our adult Black and Indian population, viz; 25% and 14.2%, respectively.2' None of our patients were receiving corticosteroids at the time of analysis and the incidence of hypertension would be expected to increase with the evolution of the disease and initiation of corticosteroids. Even at this early stage of the illness, however, hypertension appeared to be functionally significant in that both the incidence of renal functional impairment and mean serum creatinine levels were significantly higher in the hypertensives than in the normotensives. Furthermore, the presence of hypertensive renal vascular lesions identified a highrisk subgroup of patients who had a higher incidence of renal functional impairment and worse renal function than the hypertensive group as a whole (table 1). All our patients with hypertensive renal vascular lesions were hypertensive. We were unable to demonstrate a correlation between hypertension and histological class of lupus nephritis (table 2) As discussed previously lupus nephritis in our patients with systemic lupus erythematosus is common'8 and is associated with significant mortality, with approximately 25% of patients dying from end-stage renal failure.'5 As we are unable to support many of these patients on renal replacement therapy programmes it is important to be able to modify the disease at an early stage. In addition to the adverse prognosis associated with the more severe histological forms of lupus nephritis (especially WHO Class IV and high activity and chronicity indices),622-2'4 arterial hypertension is also an important, potentially modifiable risk factor for progression to end-stage renal disease.4'5 We are unable to draw any conclusions about the prognostic significance of hypertension at the onset of clinical lupus nephritis in our patients as this would require a longer period of observation. Nevertheless we were able to demonstrate an association between hypertension and impaired renal function on presentation. Furthermore, the observation that the presence of hypertensive renal vascular lesions identified a subgroup of patients with significantly worse renal function suggests that hypertension is functionally significant at an early stage of lupus nephritis. We therefore believe that, in addition to appropriate immunosuppressive therapy, early and effective treatment of arterial hypertension in patients with early lupus nephritis is essential to prevent deterioration of renal function.
